News und Analysen

Shareholders denounce Merck’s lawsuit against HHS as a transparent campaign to protect profits at the expense of patients

Shareholders Deem Merck’s Lawsuit Against HHS As Unconstitutional

NEW

New York, United State, June 7th, 2023, Chainwire

Breaking barriers in the decentralized cryptocurrency mining sector, WOW EARN announced today the successful closure of its Series A financing

Sunset legislation aims to make fundamental changes to operations at the Texas Commission on Law Enforcement, which oversees licensure of law enforcement.

Building Public Confidence In Law

• Industrials company, ‘We Soda’ has announced its intention to float on the LSE.
• The company manufactures natural soda ash, used in industrial processes and sustainable solutions.
• The listing

Key Points

• Medtronic had a solid quarter but gave weak guidance, which has shares moving lower. 
• The company and industry are rebounding from COVID so trends are favorable. 
• Cautious

Key Points

• Microbot Medical makes remote-controlled micro-robotics systems to assist medical practitioners with minimally invasive surgical procedures.
• Microbot’s LIBERTY robotic system

LONDON, UNITED KINGDOM, May 23rd, 2023, Chainwire

Vertex Labs (Vertexlabs.uk), the brain behind the Caduceus metaverse protocol, Vertex Network and 3D metaverse platform, LightCycle, has acquired

Key Points

• JAB has announced its plans to acquire Pumpkin, a pet insurance platform launched by Zoetis, which is still a minority holder.
• As Zoetis undertakes its plans for sustainable

My warning is coming true… “When the going gets tough, you lie”… US banks are more than half a trillion dollars in the red… Banks shortchanged their clients; now they’re paying the price… Trade

The new fine print in wartime cyber insurance has thrown a wrench in the works. Many boards of directors are struggling to understand it. Yet, cyber insurance is just one part of the fintech puzzle

Muddy Waters is short Chinook Therapeutics Inc (NASDAQ:KDNY) because we believe it is highly unlikely that atrasentan, its lead product candidate, will be approved by the FDA. We conclude that

Key Points

• Pfizer’s Q1 results top expectations on strength in COVID sales. 
• Ex-COVID sales grew by 5% and are expected to accelerate in the 2nd half. 
• The stock yields more than 4% and

With fresh scrutiny on the banking system following the collapse of Silicon Valley Bank, there is another aspect of the financial system that often gets less attention: the vulnerability of the